Nahdi net profit up 22% to SAR 237.5 mln in Q1 2022

Nahdi net profit up 22% to SAR 237.5 mln in Q1 2022

17/05/2022 Argaam Exclusive

View other reports

Nahdi Medical Co. reported a net profit after Zakat and tax of SAR 237.5 million for Q1 2022, a 22% increase from a profit of SAR 195 million in the same period a year earlier.



Current Quarter Comparison (M)

Compared With The
Item Q1 2021 Q1 2022 Change‬
Revenues 1,981.11 2,079.49 5.0 %
Gross Income 779.71 851.73 9.2 %
Operating Income 224.35 255.15 13.7 %
Net Income 195.02 237.51 21.8 %
Average Shares 130.00 130.00 -
EPS (Riyals) 1.50 1.83 21.8 %

The profit increase is attributed to higher sales from the pharmaceuticals segment amid a rise in coronavirus Omicron variant cases. Also, infection rates increased compared to 2021, with the easing of the related restrictions.

 

The firm’s gross profit also increased on sales growth and positive product mix.

 

Sequentially, the company’s net profit grew 65.8% from SAR 143.2 million in Q4 2021.

 

Total shareholders’ equity stood at SAR 1.84 billion as of March 31, 2022, declining by 19.1% from SAR 2.27 billion a year earlier.

View More Financial Results

 


Financial results (Million)

Period Revenues Change Gross Income Change Operating Income Change
Q1 2013 - - - - - -
Q2 2013 - - - - - -
Q3 2013 - - - - - -
Q4 2013 - - - - - -
Q1 2014 - - - - - -
Q2 2014 - - - - - -
Q3 2014 - - - - - -
Q4 2014 - - - - - -
Q1 2015 - - - - - -
Q2 2015 - - - - - -
Q3 2015 - - - - - -
Q4 2015 - - - - - -
Q1 2016 - - - - - -
Q2 2016 - - - - - -
Q3 2016 - - - - - -
Q4 2016 - - - - - -
Q1 2017 - - - - - -
Q2 2017 - - - - - -
Q3 2017 - - - - - -
Q4 2017 - - - - - -
Q1 2018 - - - - - -
Q2 2018 - - - - - -
Q3 2018 - - - - - -
Q4 2018 - - - - - -
Q1 2019 - - - - - -
Q2 2019 - - - - - -
Q3 2019 - - - - - -
Q4 2019 - - - - - -
Q1 2020 2,096.94 - 759.19 - 327.66 -
Q2 2020 2,423.57 - 946.98 - 301.33 -
Q3 2020 2,135.55 - 778.23 - 112.45 -
Q4 2020 1,986.14 - 765.27 - 183.65 -
Q1 2021 1,981.11 (5.5 %) 779.71 2.7 % 224.35 (31.5 %)
Q2 2021 2,070.14 (14.6 %) 859.97 (9.2 %) 255.14 (15.3 %)
Q3 2021 2,041.74 (4.4 %) 857.80 10.2 % 268.95 139.2 %
Q4 2021 1,973.23 (0.7 %) 807.21 5.5 % 99.44 (45.9 %)
Q1 2022 2,079.49 5.0 % 851.73 9.2 % 255.15 13.7 %


Profit Performance (Million)

Period Net Income Change EPS(Riyal) Extraordinary Income/Expense Net Profit Before Unusual Items EPS Before XO Items
Q1 2013 - - - - - -
Q2 2013 - - - - - -
Q3 2013 - - - - - -
Q4 2013 - - - - - -
Q1 2014 - - - - - -
Q2 2014 - - - - - -
Q3 2014 - - - - - -
Q4 2014 - - - - - -
Q1 2015 - - - - - -
Q2 2015 - - - - - -
Q3 2015 - - - - - -
Q4 2015 - - - - - -
Q1 2016 - - - - - -
Q2 2016 - - - - - -
Q3 2016 - - - - - -
Q4 2016 - - - - - -
Q1 2017 - - - - - -
Q2 2017 - - - - - -
Q3 2017 - - - - - -
Q4 2017 - - - - - -
Q1 2018 - - - - - -
Q2 2018 - - - - - -
Q3 2018 - - - - - -
Q4 2018 - - - - - -
Q1 2019 - - - - - -
Q2 2019 - - - - - -
Q3 2019 - - - - - -
Q4 2019 - - - - - -
Q1 2020 315.77 - 2.43 - 315.77 2.43
Q2 2020 268.73 - 2.07 - 268.73 2.07
Q3 2020 97.81 - 0.75 - 97.81 0.75
Q4 2020 166.81 - 1.28 18.00 148.81 1.14
Q1 2021 195.02 (38.2 %) 1.50 - 195.02 1.50
Q2 2021 226.83 (15.6 %) 1.74 - 226.83 1.74
Q3 2021 247.45 153.0 % 1.90 - 247.45 1.90
Q4 2021 143.23 (14.1 %) 1.10 6.70 136.54 1.05
Q1 2022 237.51 21.8 % 1.83 - 237.51 1.83

Profitability

Period Gross Margin OIBDA Margin Net Margin Before Unusual Items
Q1 2013 - - -
Q2 2013 - - -
Q3 2013 - - -
Q4 2013 - - -
Q1 2014 - - -
Q2 2014 - - -
Q3 2014 - - -
Q4 2014 - - -
Q1 2015 - - -
Q2 2015 - - -
Q3 2015 - - -
Q4 2015 - - -
Q1 2016 - - -
Q2 2016 - - -
Q3 2016 - - -
Q4 2016 - - -
Q1 2017 - - -
Q2 2017 - - -
Q3 2017 - - -
Q4 2017 - - -
Q1 2018 - - -
Q2 2018 - - -
Q3 2018 - - -
Q4 2018 - - -
Q1 2019 - - -
Q2 2019 - - -
Q3 2019 - - -
Q4 2019 - - -
Q1 2020 - - -
Q2 2020 - - -
Q3 2020 - - -
Q4 2020 37.60 % 13.58 % 9.62 %
Q1 2021 38.35 % 14.17 % 8.33 %
Q2 2021 38.95 % 15.99 % 8.18 %
Q3 2021 40.38 % 18.24 % 10.13 %
Q4 2021 40.97 % 17.60 % 9.99 %
Q1 2022 41.36 % 17.85 % 10.39 %


Per Share Data (Riyal)

Compared With The
Period Shares Outstanding (M) EPS (Riyal) Adjusted EPS (Riyal) Book Value (BV)
Q1 2013 - - - -
Q2 2013 - - - -
Q3 2013 - - - -
Q4 2013 - - - -
Q1 2014 - - - -
Q2 2014 - - - -
Q3 2014 - - - -
Q4 2014 - - - -
Q1 2015 - - - -
Q2 2015 - - - -
Q3 2015 - - - -
Q4 2015 - - - -
Q1 2016 - - - -
Q2 2016 - - - -
Q3 2016 - - - -
Q4 2016 - - - -
Q1 2017 - - - -
Q2 2017 - - - -
Q3 2017 - - - -
Q4 2017 - - - -
Q1 2018 - - - -
Q2 2018 - - - -
Q3 2018 - - - -
Q4 2018 - - - -
Q1 2019 - - - -
Q2 2019 - - - -
Q3 2019 - - - -
Q4 2019 - - - -
Q1 2020 130.00 - - -
Q2 2020 130.00 - - -
Q3 2020 130.00 - - -
Q4 2020 130.00 6.53 6.39 15.99
Q1 2021 130.00 5.60 5.46 17.49
Q2 2021 130.00 5.28 5.14 15.54
Q3 2021 130.00 6.43 6.29 11.26
Q4 2021 130.00 6.25 6.20 12.34
Q1 2022 130.00 6.58 6.53 14.15

Multiple Ratios (End of Period Price)

Compared With The
Period P/E Adjusted P/E Price/book
Q1 2013 - - -
Q2 2013 - - -
Q3 2013 - - -
Q4 2013 - - -
Q1 2014 - - -
Q2 2014 - - -
Q3 2014 - - -
Q4 2014 - - -
Q1 2015 - - -
Q2 2015 - - -
Q3 2015 - - -
Q4 2015 - - -
Q1 2016 - - -
Q2 2016 - - -
Q3 2016 - - -
Q4 2016 - - -
Q1 2017 - - -
Q2 2017 - - -
Q3 2017 - - -
Q4 2017 - - -
Q1 2018 - - -
Q2 2018 - - -
Q3 2018 - - -
Q4 2018 - - -
Q1 2019 - - -
Q2 2019 - - -
Q3 2019 - - -
Q4 2019 - - -
Q1 2020 - - -
Q2 2020 - - -
Q3 2020 - - -
Q4 2020 - - -
Q1 2021 - - -
Q2 2021 - - -
Q3 2021 - - -
Q4 2021 - - -
Q1 2022 23.57 23.75 10.95

Business Segments (Million)

Compared With The
Period Front Shop Pharma Other
Q3 2020 1,149.16 983.85 2.54
Q4 2020 1,061.26 923.31 1.57
Q1 2021 1,065.84 913.56 1.71
Q2 2021 1,135.41 924.12 10.61
Q3 2021 1,081.26 950.21 10.27
Q4 2021 1,016.84 944.85 11.54
Q1 2022 1,017.79 1,044.51 17.20


Financial Ratios
Current
Market Cap (M Riyal) 15,418.00
Enterprise Value (EV) (M) 14,670.35
Shares Outstanding ((M)) 130.00
EPS ( Riyal) (TTM) 6.41
Book Value (BV) ( Riyal) 18.53
Par Value ( Riyal) 10.00
Adjusted P/E (Last12) 19.26
P/E (TTM) 18.50
Price/book 6.40
Return on Average Assets (%) (TTM) 15.1
Return on Average Equity (%) (TTM) 35.6
more

Share Price

Nahdi Medical Co.
118.60
(1.20) (1.00 %)

Nahdi Medical Co. (NAHDI)

More

Comments {{getCommentCount()}}

Be the first to comment

{{Comments.indexOf(comment)+1}}
{{comment.FollowersCount}}
{{comment.CommenterComments}}

رد{{comment.DisplayName}} على {{getCommenterName(comment.ParentThreadID)}}

{{comment.DisplayName}} حساب موثّق

{{comment.ElapsedTime}}
loader Train
loader Train
Sorry: the validity period has ended to comment on this news
Opinions expressed in the comments section do not reflect the views of Argaam. Abusive comments of any kind will be removed. Political or religious commentary will not be tolerated.